These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


357 related items for PubMed ID: 27381341

  • 21. 12-Year outcome after normal myocardial perfusion SPECT in patients with known coronary artery disease.
    Ottenhof MJ, Wai MC, Boiten HJ, Korbee RS, Valkema R, van Domburg RT, Schinkel AF.
    J Nucl Cardiol; 2013 Oct; 20(5):748-54. PubMed ID: 23912382
    [Abstract] [Full Text] [Related]

  • 22. Prognostic implications of stress Tc-99m tetrofosmin myocardial perfusion imaging in patients with left ventricular hypertrophy.
    Elhendy A, Schinkel AF, van Domburg RT, Bax JJ, Feringa HH, Noordzij PG, Schouten O, Poldermans D.
    J Nucl Cardiol; 2007 Jul; 14(4):550-4. PubMed ID: 17679064
    [Abstract] [Full Text] [Related]

  • 23. Prediction of cardiac death in hypertensive patients with suspected or known coronary artery disease by stress technetium-99m tetrofosmin myocardial perfusion imaging.
    Elhendy A, Schinkel AF, Van Domburg RT, Bax JJ, Poldermans D.
    J Hypertens; 2003 Oct; 21(10):1945-51. PubMed ID: 14508202
    [Abstract] [Full Text] [Related]

  • 24. Long-term prognostic value of early poststress (99m)Tc-tetrofosmin lung uptake during exercise (SPECT) myocardial perfusion imaging.
    Georgoulias P, Tsougos I, Valotassiou V, Tzavara C, Xaplanteris P, Demakopoulos N.
    Eur J Nucl Med Mol Imaging; 2010 Apr; 37(4):789-98. PubMed ID: 20016896
    [Abstract] [Full Text] [Related]

  • 25. Outcome prediction in patients at high risk for coronary artery disease: comparison between 99mTc tetrofosmin and 99mTc sestamibi.
    Borges-Neto S, Tuttle RH, Shaw LK, Smith WT, Jain D, Coleman RE, Whellan D.
    Radiology; 2004 Jul; 232(1):58-65. PubMed ID: 15220493
    [Abstract] [Full Text] [Related]

  • 26. Cardiovascular risk stratification in diabetic patients following stress single-photon emission-computed tomography myocardial perfusion imaging: the impact of achieved exercise level.
    Padala SK, Ghatak A, Padala S, Katten DM, Polk DM, Heller GV.
    J Nucl Cardiol; 2014 Dec; 21(6):1132-43. PubMed ID: 25208530
    [Abstract] [Full Text] [Related]

  • 27. Adenosine triphosphate stress myocardial perfusion imaging for risk stratification of patients aged 70 years and older with suspected coronary artery disease.
    Yao Z, Zhu H, Li W, Chen C, Wang H, Shi L, Zhang W.
    J Nucl Cardiol; 2017 Apr; 24(2):429-433. PubMed ID: 26797919
    [Abstract] [Full Text] [Related]

  • 28. Improved outcome prediction by SPECT myocardial perfusion imaging after CT attenuation correction.
    Pazhenkottil AP, Ghadri JR, Nkoulou RN, Wolfrum M, Buechel RR, Küest SM, Husmann L, Herzog BA, Gaemperli O, Kaufmann PA.
    J Nucl Med; 2011 Feb; 52(2):196-200. PubMed ID: 21270455
    [Abstract] [Full Text] [Related]

  • 29. Prognostic implications of a normal stress technetium-99m-tetrofosmin myocardial perfusion study in patients with a healed myocardial infarct and/or previous coronary revascularization.
    Schinkel AF, Elhendy A, Bax JJ, van Domburg RT, Huurman A, Valkema R, Biagini E, Rizzello V, Feringa HH, Krenning EP, Simoons ML, Poldermans D.
    Am J Cardiol; 2006 Jan 01; 97(1):1-6. PubMed ID: 16377272
    [Abstract] [Full Text] [Related]

  • 30. Long-term prognostic value of dobutamine stress 99mTc-sestamibi SPECT: single-center experience with 8-year follow-up.
    Schinkel AF, Elhendy A, Van Domburg RT, Bax JJ, Valkema R, Roelandt JR, Poldermans D.
    Radiology; 2002 Dec 01; 225(3):701-6. PubMed ID: 12461248
    [Abstract] [Full Text] [Related]

  • 31. Dobutamine technetium-99m tetrofosmin SPECT imaging for the diagnosis of coronary artery disease in patients with limited exercise capacity.
    Elhendy A, Sozzi FB, Valkema R, van Domburg RT, Bax JJ, Roelandt JR.
    J Nucl Cardiol; 2000 Dec 01; 7(6):649-54. PubMed ID: 11144480
    [Abstract] [Full Text] [Related]

  • 32. Risk stratification with vasodilator stress SPECT myocardial perfusion imaging in patients with elevated cardiac biomarkers.
    Gowdar S, Ahlberg AW, Rai M, Perucki WH, Felpel KD, Savino JA, Alter EL, Henzlova MJ, Duvall WL.
    J Nucl Cardiol; 2020 Dec 01; 27(6):2320-2331. PubMed ID: 30815834
    [Abstract] [Full Text] [Related]

  • 33. Long-term prognostic implications of myocardial perfusion imaging in octogenarians: an all-comer, cohort study.
    Katsikis A, Theodorakos A, Manira V, Papaioannou S, Kolovou G, Voudris V, Koutelou M.
    Eur J Nucl Med Mol Imaging; 2017 Aug 01; 44(9):1547-1558. PubMed ID: 28597120
    [Abstract] [Full Text] [Related]

  • 34. Long-term prognostic value of dobutamine stress echocardiography compared with myocardial perfusion scanning in patients unable to perform exercise tests.
    Schinkel AF, Bax JJ, Elhendy A, van Domburg RT, Valkema R, Vourvouri E, Bountioukos M, Rizzello V, Biagini E, Agricola E, Krenning EP, Simoons ML, Poldermans D.
    Am J Med; 2004 Jul 01; 117(1):1-9. PubMed ID: 15210381
    [Abstract] [Full Text] [Related]

  • 35. The clinical value of single photon emission computed tomography myocardial perfusion imaging in cardiac risk stratification of very elderly patients (≥80 years) with suspected coronary artery disease.
    Nair SU, Ahlberg AW, Mathur S, Katten DM, Polk DM, Heller GV.
    J Nucl Cardiol; 2012 Apr 01; 19(2):244-55. PubMed ID: 22071954
    [Abstract] [Full Text] [Related]

  • 36. Prognostic value of exercise stress technetium-99m-tetrofosmin myocardial perfusion imaging in patients with normal baseline electrocardiograms.
    Elhendy A, Schinkel AF, van Domburg RT, Bax JJ, Valkema R, Huurman A, Feringa HH, Poldermans D.
    Am J Cardiol; 2006 Sep 01; 98(5):585-90. PubMed ID: 16923441
    [Abstract] [Full Text] [Related]

  • 37. Prognostic significance of fixed perfusion abnormalities on stress technetium-99m sestamibi single-photon emission computed tomography in patients without known coronary artery disease.
    Elhendy A, Schinkel AF, van Domburg RT, Bax JJ, Poldermans D.
    Am J Cardiol; 2003 Nov 15; 92(10):1165-70. PubMed ID: 14609590
    [Abstract] [Full Text] [Related]

  • 38. Usefulness of stress gated technetium-99m single photon emission computed tomographic myocardial perfusion imaging for the prediction of cardiac death in patients with moderate to severe left ventricular systolic dysfunction and suspected coronary artery disease.
    Ahlberg AW, Kazi FA, Azemi T, Katten DM, O'Sullivan DM, Papaioannou GI, Danias PG, Heller GV.
    Am J Cardiol; 2012 Jan 01; 109(1):26-30. PubMed ID: 21943938
    [Abstract] [Full Text] [Related]

  • 39. Incremental prognostic value of technetium-99m-tetrofosmin exercise myocardial perfusion imaging for predicting outcomes in patients with suspected or known coronary artery disease.
    Galassi AR, Azzarelli S, Tomaselli A, Giosofatto R, Ragusa A, Musumeci S, Tamburino C, Giuffrida G.
    Am J Cardiol; 2001 Jul 15; 88(2):101-6. PubMed ID: 11448403
    [Abstract] [Full Text] [Related]

  • 40. Comparison of exercise, dipyridamole, adenosine, and dobutamine stress with the use of Tc-99m tetrofosmin tomographic imaging.
    Levine MG, Ahlberg AW, Mann A, White MP, McGill CC, Mendes de Leon C, Piriz JM, Waters D, Heller GV.
    J Nucl Cardiol; 1999 Jul 15; 6(4):389-96. PubMed ID: 10461605
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 18.